Carbamazepine and phenytoin induced Stevens‐Johnson syndrome is associated with HLA‐B*1502 allele in Thai population
Top Cited Papers
Open Access
- 1 December 2008
- Vol. 49 (12), 2087-2091
- https://doi.org/10.1111/j.1528-1167.2008.01719.x
Abstract
Purpose: Previous studies found a strong association between HLA-B*1502 and carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS) in Han Chinese, but not in Caucasian populations. Even in Han Chinese, the HLA-B*1502 was not associated with CBZ-induced maculopapular eruptions (MPE). This study seeks to identify whether HLA-B*1502 is associated with CBZ- or phenytoin (PHT)-induced SJS or MPE in a Thai population. Methods: Eighty-one Thai epileptic patients between 1994 and 2007 from the Chulalongkorn Comprehensive Epilepsy Program were recruited. Thirty-one subjects had antiepileptic drug (AED)-induced SJS or MPE (6 CBZ-SJS, 4 PHT-SJS, 9 CBZ-MPE, 12 PHT-MPE), and 50 were AED-tolerant controls. Results: For the first time, a strong association between HLA-B*1502 and PHT-induced SJS was found (p = 0.005). A strong association was also found between the HLA-B*1502 and CBZ-induced SJS (p = 0.0005), making Thai the first non-Chinese population demonstrating such an association. Some patients, who were HLA-B*1502 and suffered from CBZ-induced SJS, could be tolerant to PHT and vice versa. This suggests that HLA-B*1502 may be a common attribute required for a Thai patient to develop SJS from these two AEDs; other different elements, however, are also needed for each AED. In addition, no association between HLA-B alleles and CBZ- or PHT-induced MPE was found. Conclusions: CBZ- and PHT-induced SJS, but not MPE, is associated with HLA-B*1502 allele in Thai population.Keywords
This publication has 10 references indexed in Scilit:
- Comparison and predictors of rash associated with 15 antiepileptic drugsNeurology, 2007
- Association between HLA‐B*1502 Allele and Antiepileptic Drug‐Induced Cutaneous Reactions in Han ChineseEpilepsia, 2007
- HLA-B locus in Caucasian patients with carbamazepine hypersensitivityPharmacogenomics, 2006
- Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactionsPharmacogenetics and Genomics, 2006
- A marker for Stevens-Johnson syndrome …: ethnicity mattersThe Pharmacogenomics Journal, 2006
- Risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in new users of antiepilepticsNeurology, 2005
- A marker for Stevens–Johnson syndromeNature, 2004
- Distribution of HLA‐B alleles in nasopharyngeal carcinoma patients and normal controls in ThailandTissue Antigens, 2002
- Anticonvulsant Hypersensitivity SyndromeDrug Safety, 1999
- The Spectrum of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Clinical Classification.Journal of Investigative Dermatology, 1994